Atlas Trials

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT01900509 · COMPLETED

Trial details

NCT number
NCT01900509
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hodgkin LymphomaNon-Hodgkin LymphomaAcute Leukemia
Start date
2013-08-01
Primary completion
2016-05-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.